Li, S., Hamann, U., & Sutter, C. (2022). Cancer risks associated with BRCA1 and BRCA2 pathogenic variants. Journal of clinical oncology, 40(14), . https://doi.org/10.1200/JCO.21.02112
Chicago-Zitierstil (17. Ausg.)Li, Shuai, Ute Hamann, und Christian Sutter. "Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants." Journal of Clinical Oncology 40, no. 14 (2022). https://doi.org/10.1200/JCO.21.02112.
MLA-Zitierstil (9. Ausg.)Li, Shuai, et al. "Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants." Journal of Clinical Oncology, vol. 40, no. 14, 2022, https://doi.org/10.1200/JCO.21.02112.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.